Squarepoint Portfolio holdings
AUM
$45.5B
1-Year Return
6.73%
This Quarter Return
+3.13%
1 Year Return
+6.73%
3 Year Return
+22.51%
5 Year Return
+41.07%
10 Year Return
+76.91%
AUM
$24.2B
AUM Growth
-$260M
(-1.1%)
Cap. Flow
-$2.31B
Cap. Flow
% of AUM
-9.51%
Top 10 Holdings %
Top 10 Hldgs %
14.13%
Holding
3,100
New
519
Increased
924
Reduced
929
Closed
588
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$736M |
| 2 |
CrowdStrike
CRWD
|
+$159M |
| 3 |
Pinduoduo
PDD
|
+$141M |
| 4 |
UnitedHealth
UNH
|
+$139M |
| 5 |
SPDR Gold Trust
GLD
|
+$126M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.12B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$249M |
| 3 |
Microsoft
MSFT
|
+$192M |
| 4 |
NVIDIA
NVDA
|
+$171M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$166M |
Sector Composition
| 1 | Technology | 20.37% |
| 2 | Consumer Discretionary | 15.2% |
| 3 | Healthcare | 10.99% |
| 4 | Financials | 10.87% |
| 5 | Industrials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
First Industrial Realty Trust
FR
$6.91B
| $465K | ﹤0.01% |
+8,848
| New | +$465K |
|
|
PARAA
1702
DELISTED
Paramount Global Class A
PARAA
| $464K | ﹤0.01% |
21,245
+565
| +3% | +$12.3K |
|
1703
Telos
TLS
$490M
| $464K | ﹤0.01% |
111,472
-18,317
| -14% | -$76.2K |
|
1704
Marqeta
MQ
$2.61B
| $461K | ﹤0.01% |
77,363
+56,131
| +264% | +$335K |
|
1705
Integra LifeSciences
IART
$1.17B
| $461K | ﹤0.01% |
12,993
-26,150
| -67% | -$927K |
|
1706
Fiverr
FVRR
$881M
| $460K | ﹤0.01% |
21,845
-10,402
| -32% | -$219K |
|
1707
Acumen Pharmaceuticals
ABOS
$80M
| $459K | ﹤0.01% |
113,232
+60,403
| +114% | +$245K |
|
1708
CytomX Therapeutics
CTMX
$330M
| $458K | ﹤0.01% |
210,151
+59,618
| +40% | +$130K |
|
1709
inTEST
INTT
$90.8M
| $457K | ﹤0.01% |
34,516
-33,156
| -49% | -$439K |
|
1710
Fractyl Health
GUTS
$72.2M
| $457K | ﹤0.01% |
+61,708
| New | +$457K |
|
1711
BlueLinx
BXC
$617M
| $455K | ﹤0.01% |
3,491
-11,660
| -77% | -$1.52M |
|
1712
Phibro Animal Health
PAHC
$1.61B
| $454K | ﹤0.01% |
35,135
-26,285
| -43% | -$340K |
|
|
GTHX
1713
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $454K | ﹤0.01% |
105,156
+88,938
| +548% | +$384K |
|
1714
Red Violet
RDVT
$679M
| $454K | ﹤0.01% |
+23,205
| New | +$454K |
|
1715
Edgewise Therapeutics
EWTX
$1.5B
| $453K | ﹤0.01% |
24,854
+13,244
| +114% | +$242K |
|
1716
VeriSign
VRSN
$26.7B
| $453K | ﹤0.01% |
2,390
-37,417
| -94% | -$7.09M |
|
1717
Amylyx Pharmaceuticals
AMLX
$1.24B
| $452K | ﹤0.01% |
159,309
+125,859
| +376% | +$357K |
|
|
SBDS
1718
Solo Brands, Inc.
SBDS
$26M
| $450K | ﹤0.01% |
207,422
+134,182
| +183% | +$291K |
|
1719
Sarepta Therapeutics
SRPT
$1.82B
| $450K | ﹤0.01% |
+3,476
| New | +$450K |
|
1720
Genie Energy
GNE
$404M
| $450K | ﹤0.01% |
+29,837
| New | +$450K |
|
1721
SPX Corp
SPXC
$9.21B
| $450K | ﹤0.01% |
+3,652
| New | +$450K |
|
1722
Trinity Industries
TRN
$2.28B
| $449K | ﹤0.01% |
+16,115
| New | +$449K |
|
1723
Agilon Health
AGL
$443M
| $447K | ﹤0.01% |
73,271
-128,926
| -64% | -$786K |
|
1724
Enphase Energy
ENPH
$4.92B
| $445K | ﹤0.01% |
3,682
-22,606
| -86% | -$2.73M |
|
|
BOLD
1725
Boundless Bio
BOLD
$25.7M
| $445K | ﹤0.01% |
+31,250
| New | +$445K |
|